Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma. - Navone SE; Marfia G; Guarnaccia L; Rizzaro M; Fiore G; Campanella R; Gaudino C; Santini D; Alotta GA; Miozzo MR; Barilla E; Locatelli M; et al. (Journal of experimental & clinical cancer research : CR, 2025)